AOCNP Certification 2026: The Complete ONCC Advanced Practice Oncology Guide
The AOCNP (Advanced Oncology Certified Nurse Practitioner) credential from the Oncology Nursing Certification Corporation (ONCC) is the gold-standard role-specific certification for nurse practitioners delivering direct care to adults with cancer. It validates advanced clinical judgment across the cancer continuum—from screening and staging through treatment, survivorship, and end-of-life care.
The overall AOCNP pass rate is approximately 83%, and candidates receive a same-day pass/fail decision at the PSI testing center. ONCC is simultaneously launching a new graduate-level credential in 2026—the Advanced Certified Oncology Nurse (ACON)—with beta testing from September 28 to November 30, 2026. AOCNP is not being retired; this guide explains exactly when AOCNP is still the right choice and when to consider the ACON beta instead.
If you hold a graduate NP degree, have logged supervised oncology hours, and want to formally signal expertise to employers, magnet hospitals, and cancer centers, AOCNP is the credential that does it. This 2026 guide walks through the latest ONCC eligibility pathways, the 165-question exam blueprint, the scaled 55 passing score, fees, the ILNA renewal method, retake rules, and a realistic study plan.
What AOCNP Actually Certifies (and Who Should Pursue It)
AOCNP is a role-specific, advanced-level credential. It is distinct from the entry-level OCN (RN-focused) and from the AOCNS (clinical nurse specialist). Holders typically work in:
- Academic cancer centers and NCI-designated comprehensive cancer centers
- Community oncology practices and infusion clinics
- Bone marrow / stem cell transplant units
- Radiation oncology consult services
- Palliative care and survivorship clinics
- Clinical trial and research roles
The credential tells employers you can independently manage complex oncology patients: interpret staging, prescribe and monitor systemic therapy, manage toxicities, handle oncologic emergencies, and lead goals-of-care conversations.
AOCNP Eligibility: Two Pathways (2026)
ONCC offers two eligibility pathways. You only need to meet one.
Pathway 1 — Oncology NP Program
- Current, active, unencumbered RN license in the US, its territories, or Canada
- Graduate degree (MSN, post-master's, or DNP) from an accredited NP program with an oncology concentration
- 500 hours of supervised clinical practice as an adult oncology nurse practitioner obtained within and/or after the graduate program, within the past 5 years
- One graduate-level oncology course of at least 2 credits (or 30 hours of oncology continuing education) within the past 5 years
Pathway 2 — General NP + Post-Graduate Hours
- Current, active, unencumbered RN license (US/territories/Canada)
- Graduate degree from an accredited NP program with concentration in adult (primary or acute), family (across lifespan), gerontology, or women's health
- 1,000 hours of practice as an adult oncology nurse practitioner obtained within and/or after the graduate program, within the past 5 years
- One graduate-level oncology course (2+ credits) or 30+ hours of oncology CE within the past 5 years
Who is NOT eligible
- Pediatric-only NPs (ONCC offers CPHON and BMTCN pathways separately)
- NPs without documented oncology clinical hours
- NPs whose oncology coursework/CE is older than 5 years
- Clinical nurse specialists (they pursue AOCNS instead)
Current employment in oncology is not required at the time of application—only that your hours and coursework were completed within the 5-year window.
AOCNP vs. OCN vs. AOCNS: Pick the Right Credential
| Credential | Level | Who It's For | Clinical Hours | Renewal |
|---|---|---|---|---|
| OCN | Entry / RN | Staff RN in adult oncology | 2,000 hrs oncology in past 4 yrs + 10 CE hrs | 4 yrs (ILNA) |
| AOCNP | Advanced / NP | Adult oncology nurse practitioner | 500 hrs (Pathway 1) or 1,000 hrs (Pathway 2) | 4 yrs (ILNA) |
| AOCNS | Advanced / CNS | Adult oncology clinical nurse specialist | 500 or 1,000 hrs as CNS | 4 yrs (ILNA) |
| AOCN | Retired for new testing | Legacy advanced credential | Renewal only (as of March 2022) | 4 yrs (ILNA) |
If you practice as an NP, AOCNP is the only current ONCC credential that matches your role. OCN is for RNs (even with graduate degrees, it under-represents NP scope). AOCN is closed to new candidates—do not pursue it.
New in 2026: ACON Beta and the AOCNP vs. ACON Decision
ONCC is launching a brand-new Advanced Certified Oncology Nurse (ACON) credential in 2026. It is not a replacement for AOCNP—ONCC has explicitly stated AOCNP continues to serve role-specific oncology NPs. ACON exists because the population of master's, PhD, and DNP-prepared oncology nurses who are not practicing as NPs (educators, navigators, research coordinators, program leaders, advanced-practice CNSs in non-CNS states) grew beyond what OCN/AOCNP/AOCNS cover.
ACON beta at a glance
- Beta testing window: September 28, 2026 – November 30, 2026
- Registration window: Open through May 15, 2026, capped at the first 150 applicants
- Beta score release: ~10–12 weeks after the beta window closes
- Format: 3 hours, 165 items (125 scored, 40 pretest per ONCC's ACON page)
- Eligibility: Active RN license, master's/PhD/DNP in nursing (oncology focus preferred), 3+ years RN within past 5, 1,000 oncology nursing hours within past 4 years, 1 graduate-level oncology course or 30 hours CE
Which credential should you pursue?
| Your role | Best credential |
|---|---|
| Adult oncology nurse practitioner delivering direct patient care | AOCNP |
| MSN/DNP oncology nurse in education, navigation, research, leadership, informatics | ACON (beta 2026) or wait for full launch |
| Adult oncology clinical nurse specialist | AOCNS |
| Staff RN in adult oncology | OCN |
| Pediatric oncology nurse | CPHON |
| Blood & marrow transplant RN | BMTCN |
If you are a practicing NP, stay with AOCNP—it is the only ONCC credential that maps directly to NP scope of practice (prescriptive authority, diagnosis, billing). The 150-slot ACON beta is best for graduate-prepared non-NP oncology nurses who want in on the ground floor.
Exam Format: What the 3-Hour Test Looks Like
| Item | Detail |
|---|---|
| Total questions | 165 multiple-choice |
| Scored / pretest split | ONCC publishes 165 total; prep sources commonly cite 145 scored + 20 pretest (some cite 125/40 — treat the split as informational, the 165-item timing is what plans around) |
| Time limit | 3 hours (includes tutorial + post-test survey) |
| Scoring method | Scaled score (25–75 range) |
| Passing score | 55 scaled |
| Overall pass rate | ~83% (widely reported; ONCC does not publish a per-cycle figure on the public candidate page) |
| Delivery | PSI testing centers (in-person) |
| Result notification | Same day pass/fail at the testing center; official scaled score report and subject-area diagnostic ~24 hours to 2 weeks later |
| Authorization-to-Test window | 90 days after ATT issued |
| Application review to ATT | Typically 2–6 weeks after a complete application |
| Certification validity | 4 years |
A scaled 55 does not mean 55%. ONCC converts raw performance across item forms of differing difficulty to the 25–75 scale so a "55" represents the same level of competence regardless of which form you took. Most references estimate this corresponds to roughly 65–75% of scored items correct—but chasing that percentage is the wrong mental model. Master the blueprint and the scaled score takes care of itself.
AOCNP Test Blueprint: Where the Points Live
The AOCNP exam is built from five content domains. These percentages drive how many questions you see from each area—study time should match.
| Domain | % of Exam | Approx. Scored Qs |
|---|---|---|
| Cancer Treatment and Supportive Care | ~45% | ~65 |
| Cancer Continuum (screening, diagnosis, staging, survivorship, end-of-life) | ~35% | ~51 |
| Oncologic Emergencies | ~10% | ~14 |
| Psychosocial Issues | ~5% | ~7 |
| Professional Practice and Roles of the APRN | ~5% | ~7 |
Always verify the current percentages against the ONCC AOCNP Test Content Outline, which ONCC updates periodically after role-delineation studies.
What "Cancer Treatment and Supportive Care" actually tests (45%)
- Systemic therapy: cytotoxic chemotherapy, targeted agents (TKIs, monoclonal antibodies), immunotherapy (checkpoint inhibitors), hormonal therapy, CAR-T cell therapy
- Radiation therapy principles: external beam, brachytherapy, skin care, site-specific toxicities
- Blood and marrow transplant: autologous vs. allogeneic, conditioning regimens, GVHD
- Symptom management: CINV (NCCN / ASCO antiemetic guidelines), neutropenic fever protocols, mucositis, pain (WHO ladder, opioid rotation, equianalgesia), chemotherapy-induced peripheral neuropathy
- Dose calculations, BSA, renal adjustment, vesicant extravasation management
- Supportive agents: G-CSF, erythropoiesis-stimulating agents, bone-modifying agents (denosumab, zoledronic acid)
Cancer Continuum (35%)
- Screening and early detection: USPSTF, ACS guidelines by site (breast, colorectal, cervical, lung LDCT, prostate)
- Genetic risk: BRCA1/2, Lynch syndrome, red flags for referral to genetic counseling
- Diagnosis & staging: TNM, pathology interpretation, biomarkers (ER/PR/HER2, PD-L1, MSI-H/dMMR, EGFR, ALK)
- Survivorship care plans, late effects, secondary malignancy surveillance
- Palliative and end-of-life care: hospice eligibility, prognostication, advance care planning, symptom management in the last weeks of life
Oncologic Emergencies (10%)
- Tumor lysis syndrome (Cairo-Bishop criteria, rasburicase, allopurinol, aggressive hydration)
- Febrile neutropenia: MASCC score, empiric antibiotics within 1 hour
- Hypercalcemia of malignancy: IV fluids, bisphosphonates, denosumab, calcitonin
- Spinal cord compression: emergent MRI + dexamethasone + radiation or surgery
- Superior vena cava syndrome
- Cytokine release syndrome (CRS) and ICANS after CAR-T — tocilizumab
- Immune-related adverse events (irAEs): colitis, pneumonitis, hepatitis, endocrinopathies → steroids per ASCO guidelines
- DIC, sepsis, hyperviscosity syndrome
Psychosocial Issues (5%)
- Distress screening (NCCN Distress Thermometer)
- Depression and anxiety, suicide risk, cancer-related cognitive impairment
- Family coping, caregiver burden, pediatric children of adult patients
- Cultural competence, health literacy, shared decision-making
Professional Practice and Roles of the APRN (5%)
- Scope of practice, prescriptive authority, DEA considerations for controlled substances
- Ethics: autonomy, informed consent, capacity, futility, moral distress
- Quality improvement, evidence-based practice, research utilization
- Interprofessional collaboration, leadership, mentoring
- Billing/coding basics for APRNs (E&M, shared visit rules)
FREE AOCNP Practice Questions Tuned to the Blueprint
Our question bank mirrors the official ONCC blueprint weightings, so practice time compounds.
- Domain-weighted sets (45% treatment/supportive, 35% continuum, etc.)
- Detailed rationales on every question, including why distractors are wrong
- AI tutor for instant explanations when a concept is not clicking
- Mobile-friendly; study on clinic breaks
Fees: What AOCNP Actually Costs in 2026
| Item | ONS / APHON Member | Non-member |
|---|---|---|
| Exam fee | $300 | $420 |
| Double-take option (one retake) | +$100 | +$100 |
| Emeritus status (retired only) | $75 one-time | $75 one-time |
| Renewal (4 yrs, on time) | ~$240 | ~$380–460 |
Ways to save: ONS membership ($128/year for full members as of early 2026) pays for itself on one application if you'll also use ONS CE toward ILNA renewal. Some employers reimburse certification fees, and the ONCC Free-Take program provides free initial testing to eligible first-time candidates whose employers have enrolled—check with your educator before applying.
Application and Scheduling Flow
- Create an ONCC account and begin the application at oncc.org
- Submit documentation: license verification, transcripts, clinical hours log signed by supervisor or program director, oncology coursework/CE evidence
- Pay exam fee
- ONCC application review: typically 2–6 weeks (budget 6 if your supervisor needs to sign the practice verification form)
- Receive Authorization to Test (ATT) email from no-reply@psiexams.com
- Schedule at a PSI testing center within your 90-day window (ATT does not extend—if you miss the window, you re-apply and re-pay)
- Arrive with two forms of ID; pass/fail result is issued the same day
ILNA Recertification: Why There's No "CE-Only" Shortcut
AOCNP certification is valid for 4 years. Renewal uses the Individual Learning Needs Assessment (ILNA) method—the defining feature of ONCC recertification.
How ILNA actually works
- Take the online Learning Needs Assessment (100–115 questions, one session, ~2 hours) by January 31 of your renewal year
- The assessment scores you against each content subject area in the current AOCNP test blueprint
- ONCC issues a personalized points requirement per subject area totaling 100 ILNA points over the 4-year cycle
- You earn points by completing professional development in those specific subject areas: ONS courses, accredited CE, academic coursework, publications, presentations, precepting
- Record points in LearningBuilder before the renewal deadline (September 15 for the $100 early-bird discount; October 15 is the final deadline)
Key distinction from many other specialty renewals: there is no generic "80 hours of any CE" option. ILNA is content-specific—if your assessment flags weakness in Oncologic Emergencies, generic leadership CE will not count toward that bucket. This design keeps certified NPs current across the whole blueprint, not just their comfort zones.
Renewal Option 2 (retesting) and Option 3 (fellowship/academic combinations) exist but are less common; most AOCNPs renew via Option 1 (ILNA).
12-Week AOCNP Study Plan (Realistic for Working NPs)
| Week | Focus | Deliverable |
|---|---|---|
| 1 | Baseline diagnostic — take a full-length practice test | Identify weakest 2 domains |
| 2–3 | Cancer Continuum — screening, genetics, staging, biomarkers | 2 question sets/day + 1 NCCN guideline |
| 4–6 | Cancer Treatment & Supportive Care (largest domain) — systemic therapy classes, radiation, symptom management | Drug class flashcards + CINV/neutropenia protocols |
| 7 | Oncologic Emergencies — TLS, neutropenic fever, SCC, SVC, CRS, irAEs | Memorize emergency algorithms |
| 8 | Psychosocial + Professional Practice | Review NCCN Distress Thermometer + APRN ethics cases |
| 9 | Second full-length practice test | Re-score against blueprint |
| 10–11 | Targeted remediation on weak domains | Focused question sets |
| 12 | Light review, sleep, test-day logistics | Pass |
Expected total: 150–200 hours. If you can only commit 10 hours/week, extend to 16 weeks rather than cramming.
Five Mistakes That Tank AOCNP Scores
- Studying oncology trivia instead of NP decision-making. The exam is a test of advanced practice, not a board review of tumor histology. Questions ask what you'd do, not what the tumor is.
- Under-weighting symptom management. CINV, pain, mucositis, neuropathy, and neutropenic fever account for a huge share of the ~45% treatment/supportive domain. Know the guidelines.
- Skipping immunotherapy and CAR-T. These are high-yield in 2026 and increasingly tested. Know irAE management and CRS/ICANS.
- Memorizing chemo regimens by cancer type. You will not be asked to recall FOLFIRINOX by name. You will be asked about dose-limiting toxicity for class (e.g., anthracyclines → cardiotoxicity, platinums → nephro/ototoxicity, vinca → neuropathy).
- Ignoring oncologic emergencies because they are only 10%. That is still ~14 scored questions. Miss half and you may miss a passing scaled score.
Test Day: What Actually Happens
- Arrive 30 minutes early. PSI centers will turn you away if you are late.
- Bring two valid IDs, one government-issued with photo and signature, both matching the name on your ATT exactly.
- Nothing in the room: no phone, smartwatch, notes, food, or drink. PSI provides a locker, a dry-erase board, and noise-reducing headphones on request.
- 165 questions in 3 hours = roughly 65 seconds per question. Flag-and-move on anything that eats more than 90 seconds; revisit after your first full pass.
- There is no penalty for guessing. Every scored question left blank is a guaranteed miss—always select something.
- Same-day pass/fail prints at the testing center. Official scaled score and subject-area performance come from ONCC within approximately 2 weeks.
If you do not pass
ONCC allows retesting, with important ground rules:
- Minimum 90 days between attempts — you cannot test more than once per 90-day window
- Three failures within three years triggers a mandatory one-year waiting period before you can test again
- The Double-Take add-on ($100 if purchased in advance of your first attempt) lets you retest once without paying the full exam fee again
Use your official ONCC subject-area diagnostic: it tells you exactly which of the five domains to rebuild. Most successful repeat-takers re-score by 3–6 scaled points on the second attempt, which is usually the difference between 52 and 55. Given the 83% overall pass rate, if you fail, you are in the 17% that usually missed by a narrow margin in 1–2 specific domains—target those, do not re-study the whole blueprint.
Deep Dive: The Symptom Management Cluster You Cannot Skip
Because roughly half the scored exam lives inside treatment and supportive care, these four symptom clusters return question after question. Have these internalized:
- CINV (chemotherapy-induced nausea/vomiting) — Classify regimens as minimal, low, moderate, or high emetic risk. High-risk cisplatin-based regimens require a 4-drug combination on day 1: NK1 antagonist (aprepitant or fosaprepitant) + 5-HT3 antagonist + dexamethasone + olanzapine (per NCCN/ASCO). Delayed CINV (days 2–4) needs continued prophylaxis, not rescue alone.
- Febrile neutropenia — ANC < 500 (or < 1,000 with expected decline) + single temp ≥ 38.3°C or sustained ≥ 38.0°C. Use MASCC score to stratify: ≥ 21 = low risk (possible outpatient oral antibiotics), < 21 = high risk (IV broad-spectrum empiric antibiotics within 1 hour).
- Cancer pain — WHO analgesic ladder; calculate morphine equivalent daily dose (MEDD) before rotating opioids; reduce cross-tolerance by 25–50% when switching; always co-prescribe a stimulant laxative.
- Chemotherapy-induced peripheral neuropathy (CIPN) — Dose-reduce or hold offending agent (taxanes, platinums, vinca, bortezomib). Duloxetine is the only agent with ASCO guideline-recommended evidence. Gabapentin and topical menthol are commonly used but with weaker support.
Career Impact: Salary and Demand
- Oncology NP median total compensation in 2026 ranges from roughly $125,000 to $201,000 depending on setting, experience, and geography (academic medical centers and transplant programs pay at the top of the range)
- NP employment overall is projected to grow ~35% this decade (U.S. Bureau of Labor Statistics)—the fastest of any advanced clinical role
- The oncology workforce gap is widening as cancer incidence rises and medical oncologist supply lags; AOCNPs are filling the gap in both academic and community settings
- Many large employers (MD Anderson, Memorial Sloan Kettering, Mayo, Dana-Farber) now prefer or require ONCC certification for oncology NP roles within 1–2 years of hire
Official Resources
- ONCC AOCNP Certification — authoritative eligibility and fees
- ONCC AOCNP Test Content Outline (PDF) — the official blueprint
- ONCC ILNA Renewal — recertification details
- ONCC Testing and Renewal — fees, deadlines, policies
- Oncology Nursing Society (ONS) — member discount source + ILNA-eligible CE
- NCCN Clinical Practice Guidelines — free to registered clinicians; a primary reference
- ASCO Guidelines — antiemetics, irAE management, survivorship
Pass AOCNP With FREE, Blueprint-Aligned Prep
Everything you need to pass the AOCNP exam—domain-weighted practice questions, rationales, AI-powered explanations, and a personalized study plan—is 100% free. No credit card, no trial wall. Join oncology NPs who use OpenExamPrep to turn a 165-question exam into a confident same-day pass.
Buy on Amazon
Practice exams on ExamEdge